We have located links that may give you full text access.
Alzheimer's disease and type 2 diabetes: what is the connection?
Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists 2015 Februrary
Alzheimer's disease (AD) is a progressive neurodegenerative condition primarily affecting individuals 65 years of age and older. There are few therapies available, and the disease is eventually fatal. Although the molecular mechanisms responsible for the development of AD remain unknown, a strong correlation between insulin dysfunction in type 2 diabetes mellitus and AD has recently been established. This has led to innovative research in the prevention and treatment of AD. Currently the most promising antidiabetic treatment options for AD are intranasal insulin and liraglutide, both of which are being investigated in ongoing clinical trials. Intranasal insulin showed promise in a pilot human trial, and while initial results appear positive, the clinical significance is unknown. Whereas current treatments only slow disease progression for a relatively short time, these new therapies may be able to reverse damage that has already occurred and potentially restore neurological function.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app